The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro

類似資料

• A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro
  著者:: Abou El Hassan, M A I, 等
  出版事項: (2003)
• Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity.
  著者:: van Acker, S. A., 等
  出版事項: (1995)
• The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study
  著者:: Bruynzeel, A M E, 等
  出版事項: (2007)
• Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice
  著者:: Bruynzeel, A M E, 等
  出版事項: (2007)
• Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells
  著者:: Bruynzeel, A M E, 等
  出版事項: (2007)